| abstract |
A method of treating obesity and related conditions, selected from eating disorders such as bulimia, anorexia, snacking and binge eating, non-insulin dependent diabetes mellitus, hyperglycaemia, hyperlipidaemia, and stress, comprising the administration of therapeutically effective amount of a compound of formula I including pharmaceutically acceptable salts, solvates, racemates, enatiomers, diastereoisomers and mixtures thereof. Most preferred compounds are 7-[1-(4-halophenoxy) ethyl] 1,2,4,-triazolo [1,5a] pyrimidines |